Atlas Trials

Treatment of Recurrent Glioblastoma With Fractionated Radiotherapy Combined With Cadonilimab

Clinical trial NCT05737368 · UNKNOWN

Trial details

NCT number
NCT05737368
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Glioblastoma
Start date
2023-02-28
Primary completion
2024-02-28
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.